Sveriges Riksbank
| Auction | Auction results |
| Auction date | 2021-02-17 |
| Settlement date | 2021-02-19 |
| Credit rating class | 1 |
| Term | 3m |
| Fixed purchase rate, % | 0.3 |
| Total bid amount, SEK mln | 0 |
| Accepted volume, SEK mln | 0 |
| Percentage alloted, % | 0 |
| Number of bids | 0 |
| Auction | Auction results |
| Auction date | 2021-02-17 |
| Settlement date | 2021-02-19 |
| Credit rating class | 1 |
| Term | 6m |
| Fixed purchase rate, % | 0.4 |
| Total bid amount, SEK mln | 0 |
| Accepted volume, SEK mln | 0 |
| Percentage alloted, % | 0 |
| Number of bids | 0 |
| Auction | Auction results |
| Auction date | 2021-02-17 |
| Settlement date | 2021-02-19 |
| Credit rating class | 2 |
| Term | 3m |
| Fixed purchase rate, % | 0.6 |
| Total bid amount, SEK mln | 0 |
| Accepted volume, SEK mln | 0 |
| Percentage alloted, % | 0 |
| Number of bids | 0 |
| Auction | Auction results |
| Auction date | 2021-02-17 |
| Settlement date | 2021-02-19 |
| Credit rating class | 2 |
| Term | 6m |
| Fixed purchase rate, % | 0.7 |
| Total bid amount, SEK mln | 0 |
| Accepted volume, SEK mln | 0 |
| Percentage alloted, % | 0 |
| Number of bids | 0 |
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novonesis (Novozymes A/S)4.11.2025 15:11:03 CET | Press release
Trading by management and close relations of management
Exterro, Inc.4.11.2025 15:00:00 CET | Press release
Exterro Joins AWS ISV Accelerate Program
ZenaTech Inc.4.11.2025 15:00:00 CET | Press release
ZenaTech’s ZenaDrone adds 15,000 sq. ft. to Dubai-Area Operations Expanding Manufacturing Capacity and Strengthening R&D for Commercial and Defense Drone Products
Calculex Inc4.11.2025 15:00:00 CET | Press release
Calculex Announces Enhanced RIPR Model 1401, Expanding Capabilities of a Proven, Fielded Recorder for Modern Defense and Aerospace Platforms
Optigo Biotherapeutics Inc.4.11.2025 15:00:00 CET | Press release
Renowned Pharma and Biotech Development Leader, Dr. Andreas Wallnöfer, is named to Optigo Biotherapeutics’ Board of Directors as the company advances to IND-enabling studies
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom